A rapid scoring technique for HER2 assessment following silver in situ hybridisation is accurate, robust and reliable

Journal of Clinical Pathology

Volumn 63, Issue 7, 2010, Pages 661-662

  Collins, Nadine ^a   Faulkes, Cate ^a   Ping, Bruno ^a   Mottolese, Marcella ^b   Sapino, Anna ^c   Di Palma, Silvana ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ANALYTIC METHOD; BREAST CANCER; CANCER DIAGNOSIS; CHROMOGENIC IN SITU HYBRIDIZATION; DIAGNOSTIC ACCURACY; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; LETTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; RELIABILITY; SCORING SYSTEM; SILVER IN SITU HYBRIDIZATION;

BREAST NEOPLASMS; FEMALE; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION; SILVER;

EID: 77955726843     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.070805     Document Type: Letter

References (5)

1. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007;25:118-45.
2. Isola J, Tanner M, Forsythe A, et al. Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization. Clin Cancer Res 2004;10:4793-8.
3. Bilous M, Morey A, Armes J, et al. Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry. Pathology 2006;38:120-4.
4. Di Palma S, Collins N, Faulkes C, et al. Chromogenic in-situ hybridisation (CISH) should be an accepted method in the routine diagnostic evaluation of HER2 status in breast cancer. J Clin Pathol 2007;60:1067-8. (Pubitemid 47441949)
5. Invitrogen. SPOT-Light HER2 CISH kit. Appendix A: HER2 CISH test interpretation guide USA. http://tools. invitrogen.com/content/sfs/manuals/ PI840150A% 20HER2%20CISH%20Kit%20Appendix%20A%20Rev% 200608.pdf (accessed 26 May 2010).